H.B. Fuller Company priced $850 million in 7.625% senior unsecured notes due 2034 to finance its planned acquisition of Advanced Medical Solutions Group plc, repay existing debt, and refinance maturing notes. The company must redeem $450 million of the new notes if the acquisition is not completed by June 25, 2027. H.B. Fuller's stock has underperformed its industry over the past year.

H.B. Fuller's stock declined slightly after reporting Q3 2026 earnings that beat adjusted earnings estimates but missed on net revenue. The chemical company reported $938 million in revenue (up 5% YoY) and $1.52 adjusted earnings per share, exceeding the $1.47 consensus estimate but falling short of the $948 million revenue projection. The company maintained full-year guidance and tightened adjusted net income guidance to $4.70-$4.85 per share.

H. B. Fuller reported Q3 2026 revenue of $938.18 million, up 5.2% year-over-year, beating consensus estimates by 0.43%. EPS of $1.52 exceeded expectations of $1.45 by 4.83%. However, the stock has underperformed the market, declining 10.4% over the past month compared to the S&P 500's 1.3% gain, and carries a Zacks Rank #4 (Sell) rating.

H. B. Fuller reported Q3 2026 earnings of $1.52 per share, beating consensus estimates of $1.45, with revenues of $938.18 million slightly exceeding expectations. However, the stock has underperformed the market by 14.1% year-to-date and carries a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends. The company's near-term outlook remains uncertain despite solid earnings performance.

H. B. Fuller is expected to report Q3 earnings of $1.46 per share (up 15.9% YoY) with revenues forecasted at $940.38 million (up 5.4% YoY). However, consensus EPS estimates have been revised 1.9% lower over the past 30 days. The stock has underperformed the market, declining 14.8% over the past month compared to the S&P 500's -1.3% change, and carries a Zacks Rank #3 (Hold) rating.

The global reactive hot melt adhesives market is expected to grow at a CAGR of 7.72% from 2025 to 2035, driven by VOC emission regulations replacing solvent-based adhesives, automotive lightweighting demands for multi-substrate bonding, and increased adoption in furniture and industrial applications. Polyurethane adhesives dominate with 48% market share, while North America and Europe lead regionally, with Asia-Pacific recording the fastest growth.

The global automotive adhesives and sealants market is projected to grow from USD 7.26 billion in 2025 to USD 13.18 billion by 2035, at a CAGR of 6.9%. Growth is driven by increased vehicle production, demand for lightweight materials, electric vehicle adoption, and stricter fuel efficiency regulations. Polyurethane-based adhesives dominate the market, with North America leading and Asia Pacific showing the fastest growth.

The global automotive sealant market is projected to grow from $8.62 billion in 2025 to $12.09 billion by 2034, with a CAGR of 3.84%. Key growth drivers include rising electric vehicle adoption, technological innovations, and increasing focus on vehicle durability and safety.

The global cyanoacrylate adhesives market is expected to grow from $2.22 billion in 2024 to $2.56 billion by 2029, with a 2.9% CAGR. Driven by demand in automotive, electronics, and medical industries, the Asia Pacific region is anticipated to be the fastest-growing market segment.

The global bioadhesives market is expected to grow from $9.65 billion in 2024 to $14.60 billion by 2029, with a CAGR of 8.6%. Asia Pacific is the fastest-growing region, driven by industrial innovation, sustainability goals, and regulatory frameworks.

The global adhesives and sealants market is projected to grow from USD 76.53 billion in 2025 to USD 126.50 billion by 2034, driven by green construction, electric vehicle adoption, and packaging innovations, with Asia Pacific leading market growth.

Robert J Martsching, VP of H.B. Fuller, executed an insider transaction of 9,546 shares, netting approximately $300,000 through employee stock options. Despite recent sales stagnation, the company shows potential for modest EPS growth and could be a solid portfolio addition.